Showing results (161-170 of 281) with videos related to

Sort By:
Pageof 29
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Pediatric Nephrology (Berlin, Germany)|January 17, 2002
The use of mycophenolate mofetil suspension in pediatric renal allograft recipientsT Bunchman, M Navarro, M Broyer, et al.
Circulation|April 11, 2001
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopeniaB E Lewis, D E Wallis, S D Berkowitz, et al.
Protein Science : a Publication of the Protein Society|December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closureKenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.
Cancer Research Communications|May 7, 2025
P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer OrganoidsBernat Navarro-Serer, Maria F Wissler, Brandi K Glover, et al.
JMIR Research Protocols|April 2, 2024
Experimentally Induced Reductions in Alcohol Consumption and Brain, Cognitive, and Clinical Outcomes in Older Persons With and Those Without HIV Infection (30-Day Challenge Study): Protocol for a Nonrandomized Clinical TrialRobert L Cook, Veronica L Richards, Joseph M Gullett, et al.
Journal of Biomolecular Screening|March 10, 2004
A strategy for discovery of novel broad-spectrum antibacterials using a high-throughput Streptococcus pneumoniae transcription/translation screenSteven D Pratt, Caroline A David, Candace Black-Schaefer, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Pageof 29